https://www.selleckchem.com/pr....oducts/Dapagliflozin
ble blood pressure device has successfully been conducted among the general adult population in Matlab, Bangladesh. As of September 2019, the pilot trial has completed enrollment of women who are pregnant (N=70; intervention n=35; control n=35) and follow-up of the participants is ongoing. Data analysis is expected to be completed by June 2020, and results are expected to be submitted for publication in August 2020. Conclusions The findings of this study will help us to design a comprehensive, full-scale randomized controlled tria
Curtir
Comentario
Compartilhar
